CHAMBERLAIN UNIVERSITY — GRADUATE NURSING CLINICAL TRACK ANXIETY DISORDERS QUESTIONS & ANSWERS (A+ GRADE)
ANXIETY DISORDERS QUESTIONS AND ANSWERS
100% VERIFIED A+ GRADE STUDY GUIDE
2026-2027 UPDATE EXAM — ADVANCED PRACTICE CLINICAL COMPREHENSIVE MANUAL
Resource Title: Anxiety Disorders Questions and ANSWERS 100% VERIFIED A+ 2023 UPDATE.docx
Subject: Advanced Practice Psychiatric-Mental Health Nursing (PMHNP) & FNP Track
Revision Cycle: 2026-2027 Academic and Clinical Update Exam Edition
Target Audience: PMHNP, FNP, and AGPCNP Clinical Candidates
Total Items: 110 High-Yield Clinical Questions with Complete Physiological Explanations
Primary Source Grounding: Psychobiological Theory, Neurotransmission, CBT, Somatoform, Pediatric, & Substance-Related
DSM-5 Guidelines
Notice to Clinical Candidates: This examination study resource is formatted strictly according to advanced practice clinical licensing
board parameters. It includes both the 75 original comprehensive questions from the primary psychiatric review document as well as 35
expanded, highly testable scenario-based items to provide extensive, 100% coverage of the material. Each question is presented on its
own distinct page to provide an unbroken, distraction-free studying experience. Emojis and other non-standard characters have been
typeset using high-contrast vector symbols (such as and ) to ensure clean rendering across all PDF systems.
CHAMBERLAIN UNIVERSITY STUDY RESOURCE — 2026-2027 UPDATE EXAM Page 1 of 112
,CHAMBERLAIN UNIVERSITY — GRADUATE NURSING CLINICAL TRACK ANXIETY DISORDERS QUESTIONS & ANSWERS (A+ GRADE)
TABLE OF CONTENTS & EXAM BLUEPRINT
Clinical Specialty Chapter Key Concepts & Clinical Procedures Covered Questions Pages
Chapter 1: Neurobiology & TCA mechanisms (Clomipramine), serotonin/norepinephrine Q1 – Q15 Pages
Psychopharmacology reuptake pathways, CYP2D6/CYP1A2 metabolism, 3–17
flumazenil reversal, benzodiazepine GABA-A chloride
channels, Beers Criteria clinical safety.
Chapter 2: Trauma & PTSD care plans, epidemiological vulnerabilities (rape, Q16 – Q35 Pages
Stressor-Related Disorders child/domestic abuse, combat), HEEADSSS adolescent 18–37
intake screening, moralistic attitudes in sexuality
discussions, safety interventions, reporting laws.
Chapter 3: Dissociative & Grounding techniques for dissociative disorders, Q36 – Q50 Pages
Somatoform Disorders unconscious displacement of somatic pain, conversion 38–52
disorder symbolic paralysis, malingering (conscious gain) vs.
somatization.
Chapter 4: Pediatric & ADHD school accommodations, methylphenidate/Ritalin Q51 – Q65 Pages
Adolescent Syndromes side effects, ODD behaviors, Autistic Spectrum Disorder 53–67
(ASD) sensory modifications, school phobia, Piaget's stages
(pre-operational).
Chapter 5: Alcohol tolerance kinetics, delirium tremens vital signs Q66 – Q80 Pages
Substance-Related & monitoring, Wernicke-Korsakoff thiamine deficits, cocaine 68–81
Detoxification toxicity nasal signs, pinpoint opioid pupils and competitive
naloxone reversal.
Chapter 6: Geriatric Delirium (acute/fluctuating) vs. Dementia (insidious), Q81 – Q95 Pages
Cognitive & Mood Disorders Alzheimer's plaques, agnosia/apraxia/aphasia, therapeutic 82–96
reality orientation, cascade iatrogenesis, Beers drug safety.
Chapter 7: Professional Primary/secondary/tertiary levels of prevention, Beers Q96 – Q110 Pages
Nursing Roles & Theory criteria prescribing, Shuler NP model domains, nurse roles 97–112
(technician, parent surrogate, ward manager, educator),
conscious/subconscious/unconscious.
Important Study Directive: This study guide is formatted with exactly **one question per page** to simulate professional computerized
testing environments. For every question, candidates should carefully review the learning objective, analyze the clinical vignette, choose their
selection, and then read the highlighted rationale block to review the anatomical, physiological, and pharmacological mechanisms governing
correct and incorrect options.
CHAMBERLAIN UNIVERSITY STUDY RESOURCE — 2026-2027 UPDATE EXAM Page 2 of 112
,CHAMBERLAIN UNIVERSITY — GRADUATE NURSING CLINICAL TRACK ANXIETY DISORDERS QUESTIONS & ANSWERS (A+ GRADE)
CHAPTER 1: NEUROBIOLOGY & PSYCHOPHARMACOLOGY
Question 1 of 110
Learning Objective: Evaluate the pharmacodynamics, metabolic pathways, and clinical indications of clomipramine (Anafranil) in OCD.
Question: Chuck is a 20-year-old student diagnosed with obsessive-compulsive behavior. A psychiatrist prescribes clomipramine (Anafranil)
to treat his condition. The nurse understands that the primary rationale for this treatment is that clomipramine:
A. Increases dopamine levels B. Increases serotonin levels
C. Decreases norepinephrine levels D. Decreases GABA levels
ANSWER : B — Increases serotonin levels
Explanation: According to the psychobiological theory, dysregulation of the neurotransmitter serotonin is thought to contribute to
obsessive-compulsive behavior. Clomipramine (Anafranil) is used to increase serotonin levels, thereby decreasing the need for
obsessive-compulsive behaviors. Clomipramine is a tricyclic antidepressant (TCA) with a potent affinity for the serotonin transporter (SERT),
effectively blocking serotonin reuptake. Dopamine levels (A) are not primarily increased by clomipramine; norepinephrine levels (C) are
moderately increased but are not the primary target for obsessive-compulsive behavior. GABA levels (D) are not directly decreased by
clomipramine.
CHAMBERLAIN UNIVERSITY STUDY RESOURCE — 2026-2027 UPDATE EXAM Page 3 of 112
, CHAMBERLAIN UNIVERSITY — GRADUATE NURSING CLINICAL TRACK ANXIETY DISORDERS QUESTIONS & ANSWERS (A+ GRADE)
CHAPTER 1: NEUROBIOLOGY & PSYCHOPHARMACOLOGY
Question 2 of 110
Learning Objective: Analyze the hepatic metabolism of clomipramine and its active metabolites in advanced clinical practice.
Question: A nurse practitioner is reviewing the pharmacokinetics of clomipramine (Anafranil). During hepatic first-pass metabolism,
clomipramine is converted to its steady-state active metabolite desmethyl clomipramine. Which of the following is true regarding this active
metabolite?
A. It has greater serotonergic activity than the parent drug. B. It is metabolized to clomipramine by CYP450 2D6.
C. It has more noradrenergic activity than serotonergic activity. D. It has a significantly shorter half-life than clomipramine.
ANSWER : C — It has more noradrenergic activity than serotonergic activity.
Explanation: Metabolism of clomipramine occurs through the liver via oxidation by CYP450 2D6. It is converted to its steady-state active
metabolite desmethyl clomipramine by CYP450 1A2. Desmethyl clomipramine has more noradrenergic activity than serotonergic activity.
Desmethyl clomipramine does not have greater serotonergic activity (A); clomipramine is converted to desmethyl clomipramine, not the
reverse (B); and desmethyl clomipramine has a prolonged half-life that contributes significantly to the clinical efficacy of the drug, rather than
being shorter (D).
CHAMBERLAIN UNIVERSITY STUDY RESOURCE — 2026-2027 UPDATE EXAM Page 4 of 112
ANXIETY DISORDERS QUESTIONS AND ANSWERS
100% VERIFIED A+ GRADE STUDY GUIDE
2026-2027 UPDATE EXAM — ADVANCED PRACTICE CLINICAL COMPREHENSIVE MANUAL
Resource Title: Anxiety Disorders Questions and ANSWERS 100% VERIFIED A+ 2023 UPDATE.docx
Subject: Advanced Practice Psychiatric-Mental Health Nursing (PMHNP) & FNP Track
Revision Cycle: 2026-2027 Academic and Clinical Update Exam Edition
Target Audience: PMHNP, FNP, and AGPCNP Clinical Candidates
Total Items: 110 High-Yield Clinical Questions with Complete Physiological Explanations
Primary Source Grounding: Psychobiological Theory, Neurotransmission, CBT, Somatoform, Pediatric, & Substance-Related
DSM-5 Guidelines
Notice to Clinical Candidates: This examination study resource is formatted strictly according to advanced practice clinical licensing
board parameters. It includes both the 75 original comprehensive questions from the primary psychiatric review document as well as 35
expanded, highly testable scenario-based items to provide extensive, 100% coverage of the material. Each question is presented on its
own distinct page to provide an unbroken, distraction-free studying experience. Emojis and other non-standard characters have been
typeset using high-contrast vector symbols (such as and ) to ensure clean rendering across all PDF systems.
CHAMBERLAIN UNIVERSITY STUDY RESOURCE — 2026-2027 UPDATE EXAM Page 1 of 112
,CHAMBERLAIN UNIVERSITY — GRADUATE NURSING CLINICAL TRACK ANXIETY DISORDERS QUESTIONS & ANSWERS (A+ GRADE)
TABLE OF CONTENTS & EXAM BLUEPRINT
Clinical Specialty Chapter Key Concepts & Clinical Procedures Covered Questions Pages
Chapter 1: Neurobiology & TCA mechanisms (Clomipramine), serotonin/norepinephrine Q1 – Q15 Pages
Psychopharmacology reuptake pathways, CYP2D6/CYP1A2 metabolism, 3–17
flumazenil reversal, benzodiazepine GABA-A chloride
channels, Beers Criteria clinical safety.
Chapter 2: Trauma & PTSD care plans, epidemiological vulnerabilities (rape, Q16 – Q35 Pages
Stressor-Related Disorders child/domestic abuse, combat), HEEADSSS adolescent 18–37
intake screening, moralistic attitudes in sexuality
discussions, safety interventions, reporting laws.
Chapter 3: Dissociative & Grounding techniques for dissociative disorders, Q36 – Q50 Pages
Somatoform Disorders unconscious displacement of somatic pain, conversion 38–52
disorder symbolic paralysis, malingering (conscious gain) vs.
somatization.
Chapter 4: Pediatric & ADHD school accommodations, methylphenidate/Ritalin Q51 – Q65 Pages
Adolescent Syndromes side effects, ODD behaviors, Autistic Spectrum Disorder 53–67
(ASD) sensory modifications, school phobia, Piaget's stages
(pre-operational).
Chapter 5: Alcohol tolerance kinetics, delirium tremens vital signs Q66 – Q80 Pages
Substance-Related & monitoring, Wernicke-Korsakoff thiamine deficits, cocaine 68–81
Detoxification toxicity nasal signs, pinpoint opioid pupils and competitive
naloxone reversal.
Chapter 6: Geriatric Delirium (acute/fluctuating) vs. Dementia (insidious), Q81 – Q95 Pages
Cognitive & Mood Disorders Alzheimer's plaques, agnosia/apraxia/aphasia, therapeutic 82–96
reality orientation, cascade iatrogenesis, Beers drug safety.
Chapter 7: Professional Primary/secondary/tertiary levels of prevention, Beers Q96 – Q110 Pages
Nursing Roles & Theory criteria prescribing, Shuler NP model domains, nurse roles 97–112
(technician, parent surrogate, ward manager, educator),
conscious/subconscious/unconscious.
Important Study Directive: This study guide is formatted with exactly **one question per page** to simulate professional computerized
testing environments. For every question, candidates should carefully review the learning objective, analyze the clinical vignette, choose their
selection, and then read the highlighted rationale block to review the anatomical, physiological, and pharmacological mechanisms governing
correct and incorrect options.
CHAMBERLAIN UNIVERSITY STUDY RESOURCE — 2026-2027 UPDATE EXAM Page 2 of 112
,CHAMBERLAIN UNIVERSITY — GRADUATE NURSING CLINICAL TRACK ANXIETY DISORDERS QUESTIONS & ANSWERS (A+ GRADE)
CHAPTER 1: NEUROBIOLOGY & PSYCHOPHARMACOLOGY
Question 1 of 110
Learning Objective: Evaluate the pharmacodynamics, metabolic pathways, and clinical indications of clomipramine (Anafranil) in OCD.
Question: Chuck is a 20-year-old student diagnosed with obsessive-compulsive behavior. A psychiatrist prescribes clomipramine (Anafranil)
to treat his condition. The nurse understands that the primary rationale for this treatment is that clomipramine:
A. Increases dopamine levels B. Increases serotonin levels
C. Decreases norepinephrine levels D. Decreases GABA levels
ANSWER : B — Increases serotonin levels
Explanation: According to the psychobiological theory, dysregulation of the neurotransmitter serotonin is thought to contribute to
obsessive-compulsive behavior. Clomipramine (Anafranil) is used to increase serotonin levels, thereby decreasing the need for
obsessive-compulsive behaviors. Clomipramine is a tricyclic antidepressant (TCA) with a potent affinity for the serotonin transporter (SERT),
effectively blocking serotonin reuptake. Dopamine levels (A) are not primarily increased by clomipramine; norepinephrine levels (C) are
moderately increased but are not the primary target for obsessive-compulsive behavior. GABA levels (D) are not directly decreased by
clomipramine.
CHAMBERLAIN UNIVERSITY STUDY RESOURCE — 2026-2027 UPDATE EXAM Page 3 of 112
, CHAMBERLAIN UNIVERSITY — GRADUATE NURSING CLINICAL TRACK ANXIETY DISORDERS QUESTIONS & ANSWERS (A+ GRADE)
CHAPTER 1: NEUROBIOLOGY & PSYCHOPHARMACOLOGY
Question 2 of 110
Learning Objective: Analyze the hepatic metabolism of clomipramine and its active metabolites in advanced clinical practice.
Question: A nurse practitioner is reviewing the pharmacokinetics of clomipramine (Anafranil). During hepatic first-pass metabolism,
clomipramine is converted to its steady-state active metabolite desmethyl clomipramine. Which of the following is true regarding this active
metabolite?
A. It has greater serotonergic activity than the parent drug. B. It is metabolized to clomipramine by CYP450 2D6.
C. It has more noradrenergic activity than serotonergic activity. D. It has a significantly shorter half-life than clomipramine.
ANSWER : C — It has more noradrenergic activity than serotonergic activity.
Explanation: Metabolism of clomipramine occurs through the liver via oxidation by CYP450 2D6. It is converted to its steady-state active
metabolite desmethyl clomipramine by CYP450 1A2. Desmethyl clomipramine has more noradrenergic activity than serotonergic activity.
Desmethyl clomipramine does not have greater serotonergic activity (A); clomipramine is converted to desmethyl clomipramine, not the
reverse (B); and desmethyl clomipramine has a prolonged half-life that contributes significantly to the clinical efficacy of the drug, rather than
being shorter (D).
CHAMBERLAIN UNIVERSITY STUDY RESOURCE — 2026-2027 UPDATE EXAM Page 4 of 112
